Bifogade filer
Nightingale Health
Prenumeration
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Nightingale Health Plc | Press Release | June 30, 2025 at 17:15:00 EEST
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and preventative health, today announced the official opening of its U.S. laboratory at the Alexandria Center® for Life Science in Long Island City, New York. The laboratory is now fully operational and serving medical research customers across the United States. This opening follows the company’s earlier announcement in April, confirming the planned launch in summer 2025.
This milestone marks a major advancement in Nightingale Health’s U.S. expansion and brings its cutting-edge services CoreMetabolomics™ and RemoteOmics™ closer to U.S. research institutions. The laboratory also provides Nightingale Health’s latest advancement in research services: Multi-omics, where both metabolomic and proteomic analysis are performed on the same samples.
“We are proud to open our U.S. laboratory and establish a local presence for analyzing medical research samples,” said Teemu Suna, CEO and Founder of Nightingale Health. “Our platform is the only solution that offers comprehensive metabolic profiling at scale, delivering metabolic insights across the full spectrum of human health. With the opening of our U.S. laboratory, we can now provide these insights more efficiently to our U.S. research customers.”
CoreMetabolomics™ includes routine lipids, apolipoproteins, amino acids, fatty acids, lipoprotein particles, inflammation and glycolysis-related metabolites, and many more. The analysis service is highly standardized and automated, resulting in affordable pricing and fast delivery times. RemoteOmics™ enables the use of reliable self-collected blood samples and delivers results that cover a wide range of biological functions. Multi-omics provides a comprehensive view of human health by analyzing both metabolic and proteomic data.
The laboratory will initially focus on providing these services to medical research customers, with preparations underway to expand services to the healthcare sector. The laboratory is designed for scalability, ensuring it can meet growing demand as Nightingale Health continues to expand its footprint in the U.S.